Surzebiclimab
Clivatuzumab
Sontuzumab
Gatipotuzumab
Minretumomab
Ensituximab
MUC1, mucin core
MUC5AC motif peptide
Gefarnate
Eudragit RS 100
Tasuldine
Ac5GalNTGc
Ac5GalNTGc epimer
Guaifenesin